Immobilization of Russian VX skin depots by localized cooling: Implications for decontamination and medical countermeasures

Toxicology Letters

Volumn 206, Issue 1, 2011, Pages 47-53

  Mikler, J ^a   Tenn, C ^b   Worek, F ^b   Reiter, G ^b   Thiermann, H ^b   Garrett, M ^a   Bohnert, S ^a   Sawyer, T W ^b  

^a DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

^b BUNDESWEHR INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (Germany)

Author keywords

Decontamination; HI 6; Hypothermia; Pralidoxime (2PAM); Reactive skin decontaminant lotion (RSDL ); Russian VX (VR)

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; ATROPINE; CHEMICAL WARFARE AGENT; CHOLINESTERASE; O ISOBUTYL S [2 (DIETHYLAMINO)ETHYL] METHYLPHOSPHONOTHIOATE; ORGANOPHOSPHORUS COMPOUND; PRALIDOXIME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APNEA; ARTICLE; CHOLINESTERASE BLOOD LEVEL; COOLING; EXPERIMENTAL PIG; EXPOSURE; HEART ARRHYTHMIA; INTOXICATION; LD 50; MALE; MASTICATION; MIOSIS; NONHUMAN; PRIORITY JOURNAL; SALIVATION; SKIN DECONTAMINATION; SURVIVAL;

ANIMALS; CHEMICAL WARFARE AGENTS; CHOLINESTERASE REACTIVATORS; CHOLINESTERASES; DECONTAMINATION; HYPOTHERMIA, INDUCED; MALE; NEUROTOXICITY SYNDROMES; ORGANOTHIOPHOSPHORUS COMPOUNDS; SKIN; SUS SCROFA; TIME FACTORS;

ANIMALIA; SUS SCROFA DOMESTICA;

EID: 80051804434     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.05.1047     Document Type: Article

References (45)

1. Aurbek N., Thiermann H., Szinicz L., Eyer P., Worek F. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase. Toxicology 2006, 224:91-99.
2. Bjarnason S., Mikler J., Hill I., Tenn C., Garrett M., Caddy N., Sawyer T.W. Comparison of selected skin decontaminant products and regimens in domestic swine. Hum. Exp. Toxicol. 2008, 27:253-261.
3. Carlsen L. A QSAR approach to physico-chemical data for organophosphates with special focus on known and potential nerve agents. Internet Electron. J. Mol. Des. 2004, EPub.
4. Chilcott R.P., Dalton C.H., Hill I., Davison C.M., Blohm K.L., Clarkson E.D., Hamilton M.G. In vivo skin absorption and distribution of the nerve agent VX (O-ethyl-S-[2(diisopropylamino)ethyl] methylphosphonothioate) in the domestic white pig. Hum. Exp. Toxicol. 2005, 24:347-352.
5. Chilcott R.P., Jenner J., Carrick W., Hotchkiss A.M., Rice P. Human skin absorption of bis-2-(chloroethyl)sulphide (sulphur mustard) in vitro. J. Appl. Toxicol. 2000, 20:349-355.
6. Crenshaw M.D., Hayes T.L., Miller T.L., Shannon C.M. Comparison of the hydrolytic stability of S-(N N-diethylaminoethyl) isobutyl methylphosphonothiolate with VX in dilute solution. J. Appl. Toxicol. 2001, 21:S3-S6.
7. Dick I.P., Scott R.C. Pig ear skin as an in vitro model for human skin permeability. J. Pharm. Pharmacol. 1992, 44:640-645.
8. Dixon W.J. The up-and-down method for small samples. Am. Stat. Assoc. J. 1965, (December):967-978.
9. Hajek P., Bajgar J., Slizova D., Krs O., Kuca K., Capek L., Fusek J. Different inhibition of acetylcholinesterase in selected parts of the rat brain following intoxication with VX and Russion VX. Drug Chem. Toxicol. 2009, 32:1-8.
10. Hamilton M.G., Hill I., Conley J.D., Sawyer T.W., Caneva D.C., Lundy P.M. Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: effects of application site and decontamination. Mil. Med. 2004, 169:856-862.
11. Johnson C.D., Russell R.L. A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations. Anal. Biochem. 1975, 64:229-238.
12. Kassa J., Jun D., Kuca K. The reactivating and therapeutic efficacy of oximes to counteract Russian VX poisoning. Int. J. Toxicol. 2006, 25:397-401.
13. Konradsen F., van der Hoek W., Cole D.C., Hutchinson G., Daisley H., Singh S., Eddleston M. Reducing acute poisoning in developing countries - options in restricting the availability of pesticides. Toxicology 2003, 197:249-261.
14. Kuca K., Jun D., Bajgar J. Currently used cholinesterase reactivators against nerve agent intoxication: comparison of their effectivity in vitro. Drug Chem. Toxicol. 2007, 30:31-40.
15. Kuca K., Jun D., Cabal J., Hrabinova M., Bartosova L., Opletalova V. Russian VX: inhibition and reactivation of acetylcholinesterase compared with VX agent. Basic Clin. Pharmacol. Toxicol. 2006, 98:389-394.
16. Luo C., Tong M., Chilukuri N., Brecht K., Maxwell D.M., Saxena A. An in vitro comparative study on the reactivation of nerve agent-inhibited guinea pig and human acetylcholinesterases by oximes. Biochemistry 2007, 46:11771-11779.
17. Luo C., Tong M., Maxwell D.M., Saxena A. Comparison of oxime reactivation and aging of nerve agent-inhibited monkey and human acetylcholinesterases. Chem. Biol. Interact. 2008, 175:261-266.
18. Lundy P.M., Raveh L., Amitai G. Development of the bisquaternary oxime HI-6 toward clinical use in the treatment of organophosphate nerve agent poisoning. Toxicol. Rev. 2006, 25:231-243.
19. Masuda N., Takatsu M., Morinari H., Ozawa T. Sarin poisoning in Tokyo subway. Lancet 1995, 345:1446-1447.
20. Maxwell D., Brecht K.M., Koplovitz I. Characterization and treatment of the toxicity of O-isobutyl S-[2-(diethylamino)ethyl]methylphosphothionate, a structural isomer of VX, in guinea pigs. J. Am. Coll. Toxicol. 1997, 15:S78-S88.
21. Maxwell D., Koplovitz I., Worek F., Sweeney R.E. A structure-activity analysis of the variation in oxime efficacy against nerve agents. Toxicol. Appl. Pharmacol. 2008, 231:157-164.
22. Morita H., Yanagisawa N., Nakajima T., Shimizu M., Hirabayashi H., Okudera H., Nohara M., Midorikawa Y., Mimura S. Sarin poisoning in Matsumoto, Japan. Lancet 1995, 346:290-293.
23. Musilek K., Kuca K., Jun D. Evaluation of potency of known oximes (pralidoxime, trimedoxime, HI-6, methoxime, obidoxime) to in vitro reactivate acetylcholinesterase inhibited by pesticides (chlorpyrifos and methylpyrifos) and nerve agent (Russian VX). Acta Med. 2007, 50:203-206.
24. Nagao M., Takatori T., Masuda Y., Nakajima M., Iwase H., Iwadate K. Definitive evidence for the acute poisoning diagnosis in the Tokyo subway. Toxicol. Appl. Pharmacol. 1997, 144:198-203.
25. Nelson P., Hill I., Conley J.D., Blohm K., Davidson C., Sawyer T.W. Therapeutic effects of cooling swine skin exposed to sulphur mustard. Mil. Med. 2008, 167:939-943.
26. Newmark J. Therapy for nerve agent poisoning. Arch. Neurol. 2004, 61:649-652.
27. Nozaki H., Aikawa N., Fujishima S., Suzuki M., Shinozawa Y., Hori S., Nogawa S. A case of VX poisoning and the difference from sarin. Lancet 1995, 346:698-699.
28. Nozaki H., Aikawa N., Shinozawa Y., Hori S., Fujishima S., Takuma K., Sagoh M. Sarin poisoning in Tokyo subway. Lancet 1995, 345:980-981.
29. Okudera H., Morita H., Iwashita T., Shibata T., Otagiri T., Kobayashi S., Yanagisawa N. Unexpected nerve gas exposure in the city of Matsumoto: report of rescue activity in the first sarin gas terrorism. Am. J. Emerg. Med. 1997, 15:527-528.
30. Reiter G., Mikler J., Hill I., Weatherby K., Thiermann H., Worek F. Chromatographic resolution, characterization and quantification of VX enantiomers in hemolyzed swine blood samples. J. Chromatogr. B 2008, 873:86-94.
31. Sawyer T.W., Mikler J., Worek F., Reiter G., Thiermann H., Tenn C., Weatherby K., Bohnert S. The therapeutic use of localized cooling in the treatment of VX poisoning. Toxicol. Lett. 2011, 204:52-56.
32. Sawyer T.W., Nelson P. Hypothermia as an adjunct therapy to vesicant induced skin injury. ePlasty 2008, 8:232-246.
33. Sawyer T.W., Risk D. Effect of low temperature on the toxicity of sulphur mustard in vitro and in vivo. Toxicology 1999, 134:27-37.
34. Sidell F.R. Nerve agents. Textbook of Military Medicine. Part I. Warfare, Weaponry and the Casualty. Medical Aspects of Chemical and Biological Warfare 1997, 129-179. Office of the Surgeon General, US Army, Falls Church, VA. first ed. F.R. Sidell, T.E. Takafuji, D.R. Franz (Eds.).
35. Singh S., Zhao K., Singh J. In vitro permeability and binding of hydrocarbons in pig ear and human abdominal skin. Drug Chem. Toxicol. 2002, 25:83-92.
36. Suzuki J., Kohno T., Tsukagosi M., Furuhata T., Yamazaki K. Eighteen cases exposed to sarin in Matsumoto. Jpn. Int. Med. 1997, 36:466-470.
37. Suzuki T., Morita H., Ono K., Maekawa K., Nagai R., Yazaki Y. Sarin poisoning in Tokyo subway. Lancet 1995, 345:980.
38. Taysee L., Daulon S., Delamanche S., Bellier B., Breton P. Skin decontamination of mustards and organophosphates: comparative efficiency of RSDL and Fuller's earth in domestic swine. Hum. Exp. Toxicol. 2007, 26:135-141.
39. Tenn C.C., Mikler J.R., Hill I., Weatherby K., Garrett M., Caddy N., Sawyer T.W., Wilgus H., Turcotte C., Huang Y., Karatzas C. Therapeutic efficacy of recombinant human butyrylcholinesterase (rBChE) against VX in anaesthetized domestic swine. J. Med. CBR Def. 2008, 6. online publication.
40. United Nations Security Council, Report of the Mission Dispatched by the Secretary General to Investigate Allegations of the Use of Chemical Weapons in the Conflict Between the Islamic Republic of Iran and Iraq, March 12, 1986, S/17911, S/17911/Addendum 1 and S/17911/Addendum 2. United Nations, New York, NY, 1986.
41. United Nations Security Council, Report of the Mission Dispatched by the Secretary-General to Investigate Allegations of the Use of Chemical Weapons in the Conflict Between the Islamic Republic of Iran and Iraq, May 8, 1987, S/18852 and S/18852/Addendum. United Nations, New York, NY, 1987.
42. United Nations Security Council, Report of the Mission Dispatched by the Secretary-General to Investigate Allegations of the Use of Chemical Weapons in the Conflict Between the Islamic Republic of Iran and Iraq, April 25, 1988, S/19823 and S/19823/Addendum 1; July 20, 1988, S/20060 and S/20060/Addendum 1; July 25, 1988, S/20063 and S/20063/Addendum 1; August 19, 1988, S/20134. United Nations, New York, NY, 1988.
43. Wiener S.W., Hoffman R.S. Nerve agents: a comprehensive review. J. Intensive Care Med. 2004, 19:22-37.
44. Worek F., Aurbek N., Wetherell J., Pearce P., Mann T., Thiermann H. Inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds: pig versus minipig acetylcholinesterase. Toxicology 2008, 244:25-44.
45. Worek F., Thiermann H., Szincz L., Eyer P. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochem. Pharmacol. 2004, 68:2237-2248.